Biological response modifiers (also referred to as cytokines) comprise a group of products intrinsic to the body that alter immune defenses to enhance, direct or restore the body's ability to fight diseases. As of mid-2002, there were 18 biological response modifiers on the market and about 20 new products/new indications in Phase III trials.
This report analyzes and assesses biological response modifiers by category and by disease application. Disease applications include anemia, bone marrow transplantation, cancer, cardiovascular diseases, infectious diseases, inflammatory diseases and multiple sclerosis. Included in this report are analyses of marketed biological response modifiers in Phase III or later development. Market projections are provided through 2007. Technology issues and breakthroughs as well as industry trends are also discussed. Profiles are provided for leading biotechnology and big pharma companies involved in the biological response modifiers market as well as for companies developing innovative products not yet launched.
View Cart
